Original InvestigationStatins for Prevention of Cardiovascular Events in a Low-Risk Population With Low Ankle Brachial Index
Key Words
Abbreviations and Acronyms
Cited by (0)
This project was supported by clinical research grants from the Ministerio de Salud (EC10-84, EC10-83); Spain's Ministry of Science and Innovation through the Carlos III Health Institute, cofinanced with European Union ERDF funds (Network for Prevention and Health Promotion in primary Care RedIAPP RD12/0005, Programa HERACLES RD12/0042, and Miguel Servet Contract CP12/03287); and by the Departament de Salut, Generalitat de Catalunya, Agency for Health Technology Assessment (AATRM 034/33/02), and Agency for Management of University and Research Grants (2005SGR00577). Drs. Ramos and Garcia-Gil collaborate (without receiving any personal fee) in 2 projects of primary care for the institute IDIAP Jordi Gol funded by AstraZeneca and AMGEN that are unrelated to the present work. Dr. Marrugat has received lecture fees from Ferrer-in-Code; holds a patent with Gendiag SL; and has received payment for development of educational presentations from AstraZeneca. Dr. Bolíbar has signed collaborations as a scientific director of the IDIAP Jordi Gol with several drug companies interested in using the SIDIAP data for research purposes (Sanofi, AstraZeneca, AMGEN, Bioiberica, Novartis, and Merck Sharp & Dohme), none of which are related to the present work. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Drs. Ramos and Garcia contributed equally to this work.